British drugs firm Shire buys ViroPharma for $4.2 bln
- Published: 11/11/2013 at 03:49 PM
- Online news:
British drugs group Shire said on Monday that it has agreed to buy US-based ViroPharma, a rare disease biopharmaceutical firm, for $4.2 billion (3.1 billion euros).
This file illustration photo, taken on April 16, 2013, shows a doctor carrying out experiments at a laboratory
"Shire plc and ViroPharma Incorporated today announce that their boards of directors have unanimously approved, and the companies have entered into, a merger agreement pursuant to which Shire will acquire all the outstanding shares of the rare disease company ViroPharma for ... a total consideration of approximately $4.2 billion," the pair said in a statement.
About the author
- Writer: AFP
Position: News agency